Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis

QR Code

Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis

Background: Individuals with metabolic syndrome (MetS) are at increased risk of cardiovascular disease (CVD), often requiring combination drug therapy for control of risk factors and subsequent risk reduction. This study aims to compare the long-term effectiveness and cost effectiveness of the polyp...

Full description

Bibliographic Details
Main Authors:	Zomer, E., Owen, A., Magliano, D., Ademi, Z., Reid, Christopher, Liew, D.
Format:	Journal Article
Published:	2013
Online Access:	http://hdl.handle.net/20.500.11937/8893

Similar Items

Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms
by: Zomer, E., et al.
Published: (2014)

More or less physical activity and the effect on cardiovascular mortality in a high-risk population
by: Zomer, E., et al.
Published: (2011)

Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: The 'old' versus the 'new' Framingham equation
by: Zomer, E., et al.
Published: (2011)

The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: Best case scenario analysis using a Markov model
by: Zomer, E., et al.
Published: (2012)

The Effect of a Cardiovascular Polypill Strategy on Pill Burden.
by: Truelove, M., et al.
Published: (2015)

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)

An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial
by: Laba, T., et al.
Published: (2014)

Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)

The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
by: Harding, J., et al.
Published: (2015)

Cost-effectiveness of renal denervation therapy for treatment-resistant hypertension: A best case scenario
by: Chowdhury, E., et al.
Published: (2018)

Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013)

Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: A randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
by: Liu, H., et al.
Published: (2010)

Cost-effectiveness of angiotensin-converting enzyme inhibitor-based compared to thiazide diuretic-based treatment in an elderly hypertensive population considering diabetes as a major comorbidity
by: Chowdhury, E., et al.
Published: (2015)

Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort
by: Ademi, Z., et al.
Published: (2013)

Overview of pharmacoeconomic modelling methods
by: Ademi, Z., et al.
Published: (2013)

Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry
by: Ademi, Z., et al.
Published: (2011)

Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region
by: Lee, Crystal, et al.
Published: (2008)

Effects of psyllium on metabolic syndrome risk factors
by: Pal, Sebely, et al.
Published: (2012)

Metabolic Syndrome
by: Hill, Kylie
Published: (2014)

COST-UTILITY ANALYSIS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-BASED TREATMENT COMPARED TO THIAZIDE DIURETIC-BASED TREATMENT IN AN ELDERLY HYPERTENSIVE POPULATION CONSIDERING MAJOR COMORBIDITIES AT THE COMMUNITY LEVEL
by: Chowdhury, E., et al.
Published: (2014)

Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-Analysis of randomised clinical trials
by: Selak, V., et al.
Published: (2019)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
by: Cenin, Dayna, et al.
Published: (2018)

Serum Alanine Aminotransferase, Metabolic Syndrome, and Cardiovascular Disease in an Australian Population
by: Olynyk, John, et al.
Published: (2008)

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome
by: Ooi, E., et al.
Published: (2008)

The effect of metformin on the metabolic parameters in polycystic ovarian syndrome.
by: Dahlia Abd Malik,, et al.
Published: (2014)

Metabolic syndrome in Iran
by: Berenjy, Shila, et al.
Published: (2010)

COST-EFFECTIVENESS OF RENAL DENERVATION THERAPY FOR TREATMENT RESISTANT HYPERTENSION: A BEST CASE SCENARIO
by: Chowdhury, E., et al.
Published: (2018)

Orange juice consumption and its effect on blood lipid profile and indices of the metabolic syndrome; a randomised, controlled trial in an at-risk population
by: Simpson, E. J., et al.
Published: (2016)

Protective effects of Nigella sativa on metabolic syndrome in menopausal women
by: Mohamad Ibrahim, Ramlah, et al.
Published: (2014)

Effects of tocotrienol supplementation on platelet aggregation in subjects with metabolic syndrome
by: Gan, Yee Lin
Published: (2014)

Associations of public transport accessibility with walking, obesity, metabolic syndrome and diabetes
by: Barr, A., et al.
Published: (2016)

Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)

A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk
by: Patel, A., et al.
Published: (2015)

Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
by: Ademi, Z., et al.
Published: (2014)

3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles
by: Khaled, Shaban A., et al.
Published: (2015)

DEVELOPMENT OF A CARDIOVASCULAR MORTALITY RISK PREDICTION MODEL FOR PARTICIPANTS IN THE OHASAMA STUDY
by: Huq, M., et al.
Published: (2014)

Preventive effect of Nigella sativa on metabolic syndrome in menopause induced rats.
by: Parhizkar, Saadat, et al.
Published: (2011)

Effectiveness of physical activity intervention among government employees with metabolic syndrome
by: Chee, Huei Phing, et al.
Published: (2017)

Predicting the metabolic energy costs of bipedalism using evolutionary robotics
by: Sellers, William Irvin, et al.
Published: (2003)

Metabolic syndrome and level of lipopolysaccharide binding protein: proportionate, associated factors and the effectiveness study of probiotics supplementation among population in Sharjah, UAE
by: Harfeel, Sondos Abd-Erraheem Jameel
Published: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dhfu5g0b5l5dsi8lb1sptjqmlr